01 October 2005
Cost effectiveness of positron emission tomography in Canada.
J Scott Sloka, Peter D HollettMed Sci Monit 2005; 11(10): PH1-6 :: ID: 430329
Abstract
BACKGROUND: Positron emission tomography (PET) has been shown to be costeffective for the staging of stage I and II breast cancer, recurrent colorectal cancer and non smallcell lung cancer. This study determines a required catchment size for the management of these three cancersbased on a breakeven analysis. MATERIAL/METHODS: Cost effectiveness analysis is used to determine thecost savings of introducing PET into the diagnostic algorithm for the staging of stage I and II breastcancer, recurrent colorectal cancer and non small cell lung cancer. The cost savings for these cancersare used to calculate a required catchment area for the installation of a PET center with cyclotron.RESULTS: The aggregate estimated "breakeven" cost of a PET study would be dollars 2195, well below theexpected cost per study. In order to break even, each PET device would require 740 new cases per year.For a general representative population, one person per 766 may benefit from a PET scan if a PET studywas included in the diagnostic algorithm for all three cancers. Finally, a calculated catchment sizeof 567,000 people would support the use of a PET center with cyclotron CONCLUSIONS: The use of PET forthe staging of cancer appears to be cost effective in most jurisdictions in Canada.
Keywords: Canada, Breast Neoplasms - radionuclide imaging, Carcinoma, Non-Small-Cell Lung - radionuclide imaging, Colorectal Neoplasms - radionuclide imaging, Cost-Benefit Analysis, Lung Neoplasms - radionuclide imaging, Positron-Emission Tomography - economics
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952